INVESTIGADORES
MORENO Griselda Noemi
congresos y reuniones científicas
Título:
Adjuvant capacity of a microbial component to enhance immunity against Bordetella pertussis
Autor/es:
JULIETA FERNÁNDEZ; GRISELDA MORENO; FEDERICO SISTI; JEAN CLAUDE SIRARD; MARTÍN RUMBO; DANIELA HOZBOR
Lugar:
Mar del Plata. Buenos Aires
Reunión:
Congreso; XLIIIReunión Anual de la Sociedad Argentina de Investigación en Bioquímica y Biología Molecular (SAIB); 2007
Institución organizadora:
Sociedad Argentina de Investigación Bioquímica y Biología Molecular
Resumen:
<!--
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-parent:"";
margin:0cm;
margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman";
mso-ansi-language:EN-US;}
@page Section1
{size:612.0pt 792.0pt;
margin:70.85pt 3.0cm 70.85pt 3.0cm;
mso-header-margin:36.0pt;
mso-footer-margin:36.0pt;
mso-paper-source:0;}
div.Section1
{page:Section1;}
-->
Bordetella
pertussis (Bp) is
the etiological agent of pertussis or whooping cough, an important respiratory
disease, which remains a problem in public health even in countries with high vaccination
coverage. Because of that, research on pertussis is mainly focused on
development of new strategies towards a better disease control. In this work we
analyze the adjuvant capacity of a microbial component flagellin of Salmonella enterica serovar typhimurium (Fla)- in a mucosal pertussis vaccination. We
analyzed the innate immune response of mice intranasally stimulated with either
Bp or Bp + Fla,
by real time RT-PCR. Specific primers for chemokine CCL20 and the cytokines
TNF-a and IL-6 were used. We observed that CCL20 and IL-6 expression was enhanced
when mice were challenged with Bp + Fla (33 ± 2 for CCL20
and 192 ± 29 for IL-6) compared to Bp alone
(9.7 ± 1.2 for CCL20 and 65 ± 22 for IL-6). We also analyzed the adjuvant
capacity of flagellin in lethal-dose pertussis protection assay. In these
experiments mice were intranasally immunized with dead whole cell bacteria with
or without flagellin as adjuvant and then challenged with live B. pertussis (109 CFU per 50
µl). The results obtained showed that flagellin behaves as a good adjuvant
since more animals survived in the experiments (44% compared to 33%)